Information obtained indicates that according to the latest data from the Hong Kong Stock Exchange, on July 7th, ND MEDICAL TECHNOLOGY LIMITED sold 2.748 million shares of CH FRONTIER TEC (01661). The transaction was executed at a price of approximately HK$1.5141 per share, resulting in a total consideration of around HK$4.1607 million.
Following this disposal, the company's remaining shareholding stands at 21.016 million shares. This represents a stake of 11.04% in the company.
The reported transaction involved other connected parties, including Wu Meizhen.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments